| David Martin, PT | |
|
1500 Vestal Pkwy E, Vestal, NY 13850-1830 | |
| (607) 240-9120 | |
| Not Available |
| Full Name | David Martin |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 1500 Vestal Pkwy E, Vestal, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073771622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT019277 (Pennsylvania) | Secondary |
| 225100000X | Physical Therapist | 62034406 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David Martin, PT 1012 Little Meadows Rd, Warren Center, PA 18851-7726 Ph: (570) 395-0190 | David Martin, PT 1500 Vestal Pkwy E, Vestal, NY 13850-1830 Ph: (607) 240-9120 |
News Archive
In a meeting at the White House Wednesday, a group of state insurance commissioners expressed concerns about President Barack Obama's proposal to extend canceled plans for one year that don't meet the requirements of the health law and both sides acknowledged that each state must come to its own decision about how to proceed.
The molecular imaging power of PET/CT is invaluable in noninvasively monitoring Crohn's disease,a chronic inflammatory disease of the gastrointestinal tract that mainly affects young people, according to a study released by Belgian scientists at the 54th Annual Meeting of SNM.
Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration has granted marketing approval for XIFAXAN 550 mg tablets for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older. HE is a serious disorder caused by chronic liver failure, resulting in cognitive, psychiatric and motor impairments. This approval was supported by findings from the largest randomized trial of maintenance therapy in HE conducted to date, which assessed the efficacy and safety of XIFAXAN 550 mg tablets and demonstrated a statistically significant and clinically meaningful reduction in the risk of overt HE recurrence.
Users of both electronic nicotine delivery systems (ENDS) and cigarettes may be more intent on quitting tobacco, but that intention seems to drop off among less educated smokers, according to a study by Georgia State University researchers published in the journal Addictive Behaviors.
› Verified 1 days ago
Thomas L Komor, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 4433 Vestal Pkwy E, Vestal, NY 13850 Phone: 607-762-2176 | |
John Todd Mansfield, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Front St, Suite D, Vestal, NY 13850 Phone: 607-754-1776 Fax: 607-748-5465 | |
Mrs. Brittany Mallonga, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1105 Hillside Dr, Vestal, NY 13850 Phone: 607-759-0968 | |
Dr. Katherine S Barnhart, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3101 Shippers Rd Ste 108, Vestal, NY 13850 Phone: 607-251-2200 | |
Anjana Ashok, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1715 Castle Gardens Rd, Suite 105, Vestal, NY 13850 Phone: 607-484-5079 Fax: 631-467-0928 | |
Mr. Matthew John Mcmahon, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 200 Front St, Suite D, Vestal, NY 13850 Phone: 607-754-1776 Fax: 607-748-5465 |